(S (NP (NP (NP (NNP Alzheimer) (POS 's)) (NN disease)) (PRN (-LRB- -LRB-) (NP (NNP AD)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT the) (ADJP (RBS most) (JJ common)) (JJ neurodegenerative) (NN disease)) (PP (IN in) (NP (JJR older) (NNS people))))) (. .))
(S (PP (IN Despite) (NP (JJ considerable) (NNS efforts) (S (VP (TO to) (VP (VB find) (NP (NP (DT a) (NN cure)) (PP (IN for) (NP (NNP AD))))))))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (ADJP (CD 99.6) (NN %)) (NN failure) (NN rate)) (PP (IN of) (NP (NP (JJ clinical) (NNS trials)) (PP (IN for) (NP (NNP AD) (NNS drugs)))))) (, ,) (ADJP (ADVP (RB likely)) (SBAR (IN because) (S (NP (NNP AD) (NNS patients)) (VP (MD can) (RB not) (VP (ADVP (RB easily)) (VB be) (VP (VBN identified) (PP (IN at) (NP (JJ early) (NNS stages)))))))))) (. .))
(S (NP (DT This) (NN project)) (VP (VBD investigated) (NP (NP (NN machine) (NN learning) (NNS approaches)) (SBAR (S (VP (TO to) (VP (VB predict) (NP (NP (DT the) (JJ clinical) (NN state)) (PP (IN of) (NP (NNS patients)))) (PP (IN in) (NP (JJ future) (NNS years))) (S (VP (TO to) (VP (VB benefit) (NP (NNP AD) (NN research))))))))))) (. .))
(S (NP (NP (JJ Clinical) (NNS data)) (PP (IN from) (NP (CD 1737) (NNS patients)))) (VP (VP (VBD was) (VP (VBN obtained) (PP (IN from) (NP (NP (DT the) (NP (NNP Alzheimer) (POS 's))) (NNP Disease) (NNP Neuroimaging) (NNP Initiative) (PRN (-LRB- -LRB-) (NNP ADNI) (-RRB- -RRB-)) (NN database))))) (CC and) (VP (VBD was) (VP (VBN processed) (S (VP (VBG using) (NP (NP (DT the) (`` ``) (JJ All-Pairs) ('' '') (NN technique)) (, ,) (NP (NP (DT a) (JJ novel) (NN methodology)) (VP (VBD created) (PP (IN for) (NP (DT this) (NN project)))) (VP (VBG involving) (NP (NP (DT the) (NN comparison)) (PP (IN of) (NP (NP (DT all) (JJ possible) (NNS pairs)) (PP (IN of) (NP (JJ temporal) (NNS data) (NNS points))) (PP (IN for) (NP (DT each) (NN patient)))))))))))))) (. .))
(S (NP (DT This) (NN data)) (VP (VBD was) (ADVP (RB then)) (VP (VBN used) (S (VP (TO to) (VP (VB train) (NP (JJ various) (NN machine) (NN learning) (NNS models))))))) (. .))
(S (NP (NNS Models)) (VP (VBD were) (VP (VP (VBN evaluated) (S (VP (VBG using) (NP (NP (JJ 7-fold) (NN cross-validation)) (PP (IN on) (NP (DT the) (NN training) (NN dataset))))))) (CC and) (VP (VBD confirmed) (S (VP (VBG using) (NP (NP (NNS data)) (PP (IN from) (NP (NP (DT a) (JJ separate) (NN testing) (NN dataset)) (PRN (-LRB- -LRB-) (NP (CD 110) (NNS patients)) (-RRB- -RRB-)))))))))) (. .))
(S (NP (DT A) (JJ neural) (NN network) (NN model)) (VP (VBD was) (ADJP (JJ effective)) (PRN (-LRB- -LRB-) (S (NP (JJ mAUC)) (VP (NNP =) (NP (CD 0.866)))) (-RRB- -RRB-)) (PP (IN at) (S (VP (VBG predicting) (NP (NP (DT the) (NN progression)) (PP (IN of) (NP (NNP AD)))) (PP (IN on) (NP (DT a) (JJ month-by-month) (NN basis))) (, ,) (PP (DT both) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (ADVP (RB initially)) (ADJP (RB cognitively) (JJ normal))))))) (CC and) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG suffering) (PP (IN from) (NP (JJ mild) (JJ cognitive) (NN impairment))))))))))) (. .))
(S (NP (JJ Such) (DT a) (NN model)) (VP (MD could) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB identify) (NP (NP (NNS patients)) (UCP (PP (IN at) (NP (NP (JJ early) (NNS stages)) (PP (IN of) (NP (NNP AD))))) (CC and) (SBAR (WHNP (WP who)) (S (VP (VBP are) (ADVP (RB therefore)) (NP (NP (JJ good) (NNS candidates)) (PP (IN for) (NP (NP (JJ clinical) (NNS trials)) (PP (IN for) (NP (NNP AD) (NNS therapeutics))))))))))))))))) (. .))
